These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14225879)

  • 1. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 2. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S; CARLSTROEM G
    Arch Gesamte Virusforsch; 1963 Aug; 13():548-58. PubMed ID: 14085248
    [No Abstract]   [Full Text] [Related]  

  • 3. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 4. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S
    Br Med J; 1965 Mar; 1(5438):813-7. PubMed ID: 14258844
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDIES ON IMMUNITY TO MEASLES.
    KRUGMAN S; GILES JP; FRIEDMAN H; STONE S
    J Pediatr; 1965 Mar; 66():471-88. PubMed ID: 14264306
    [No Abstract]   [Full Text] [Related]  

  • 6. Some characteristics of immunity following natural measles and various forms of immunization.
    Enders-Ruckle G
    Arch Gesamte Virusforsch; 1967; 22(1):23-34. PubMed ID: 5602131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 8. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 9. OBSERVATIONS ON THE FURTHER ATTENUATION OF MEASLES VIRUS AND ON LIVE VACCINES PREPARED FROM HIGHLY ATTENUATED LINES OF VIRUS.
    CHU CM; KU YF; CHANG YH
    Chin Med J; 1964 Aug; 83():483-96. PubMed ID: 14174535
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 12. A REGIMEN FOR IMMUNIZATION AGAINST MEASLES. INACTIVATED VACCINE WITH DPT AND LIVE VACCINE AT AGE 9 MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    JAMA; 1965 Mar; 191():1067-70. PubMed ID: 14261887
    [No Abstract]   [Full Text] [Related]  

  • 13. Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin.
    Norrby E; Lagercrantz R; Gard S; Carlström G
    Acta Paediatr Scand; 1965 Nov; 54(6):581-6. PubMed ID: 5832151
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of measles neutralizing and hemagglutination-inhibition antibody titers in individual sera.
    Fulginiti VA; Kempe CH
    Am J Epidemiol; 1965 Sep; 82(2):135-42. PubMed ID: 5828888
    [No Abstract]   [Full Text] [Related]  

  • 15. A NATIONWIDE SERUM SURVEY OF UNITED STATES MILITARY RECRUITS, 1962. 3. MEASLES AND MUMPS ANTIBODIES.
    BLACK FL
    Am J Hyg; 1964 Nov; 80():304-7. PubMed ID: 14225920
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RESPONSE OF VOLTA CHILDREN TO JET INOCULATION OF COMBINED LIVE MEASLES, SMALLPOX AND YELLOW FEVER VACCINES.
    MEYER HM; HOSTETLER DD; BERNHEIN BC; ROGERS NG; LAMBIN P; CHASSARY A; LABUSQUIERE R; SMADEL JE
    Bull World Health Organ; 1964; 30(6):783-94. PubMed ID: 14215185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 19. COMPARISON OF THE HEMAGGLUTINATION INHIBITION TEST FOR MEASLES WITH SEROLOGICAL TESTS AND ITS APPLICATION TO A FIELD TRIAL.
    KUNITA N; KITAWAKI T; FUNAHASHI S; TOYOSHIMA K
    Biken J; 1963 Jul; 6():45-56. PubMed ID: 14147705
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.